ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,682.40
0.00%
S&P ASX All Technology
3,019.20
0.00%
Brent Oil
83.475
0.42%
US Dollar vs AUD
1.50994
-0.19%
Bitcoin
63,219.39
-1.22%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AbSci Corporation (ABSI)

  7. AbSci Corporation (ABSI) News

ABSI

AbSci (ABSI)

AbSci Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ABSI
DateTimeSourceHeadlineSymbolCompany
16/04/202422:00GlobeNewswire Inc.Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024NASDAQ:ABSIAbSci Corporation
29/03/202407:05GlobeNewswire Inc.Absci to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
21/03/202422:30GlobeNewswire Inc.Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating ResultsNASDAQ:ABSIAbSci Corporation
02/03/202408:01GlobeNewswire Inc.Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:ABSIAbSci Corporation
29/02/202408:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
29/02/202400:34Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
28/02/202414:20GlobeNewswire Inc.Absci Announces Pricing of Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
28/02/202408:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
28/02/202408:40Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ABSIAbSci Corporation
28/02/202408:01GlobeNewswire Inc.Absci Announces Proposed Public Offering of Common StockNASDAQ:ABSIAbSci Corporation
21/02/202423:30GlobeNewswire Inc.Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AINASDAQ:ABSIAbSci Corporation
21/02/202400:00GlobeNewswire Inc.Absci to Participate in Upcoming Investor ConferencesNASDAQ:ABSIAbSci Corporation
14/02/202410:16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABSIAbSci Corporation
06/02/202411:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202411:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202411:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
06/02/202411:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
10/01/202423:30GlobeNewswire Inc.Absci Appoints Professor Sir Mene Pangalos to its Board of DirectorsNASDAQ:ABSIAbSci Corporation
08/01/202423:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
08/01/202423:00GlobeNewswire Inc.Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
05/01/202408:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
05/01/202408:57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABSIAbSci Corporation
04/01/202400:00GlobeNewswire Inc.Absci to Participate in the 26th Annual Needham Growth ConferenceNASDAQ:ABSIAbSci Corporation
29/12/202300:00GlobeNewswire Inc.Absci to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ABSIAbSci Corporation
21/12/202300:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
20/12/202323:30GlobeNewswire Inc.Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineNASDAQ:ABSIAbSci Corporation
08/12/202300:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
05/12/202302:41Dow Jones NewsAbsci Shares Rise 27% After Announcing Collaboration With AstraZenecaNASDAQ:ABSIAbSci Corporation
04/12/202323:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABSIAbSci Corporation
04/12/202323:30GlobeNewswire Inc.Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology CandidateNASDAQ:ABSIAbSci Corporation
 Showing the most relevant articles for your search:NASDAQ:ABSI

Your Recent History

NASDAQ
AMZN
Amazon.com
ASX
WOW
Woolworths
NASDAQ
MSFT
Microsoft
ASX
XAO
Australian SE All Ordina...
FX
GBPAUD
Sterling vs AUD
ASX
NCM
Newcrest Mining
ASX
WBC
Westpac Banking
ASX
BHP
BHP
FX
AUDUSD
AUD vs US Dollar
ASX
WES
Wesfarmers
FTSE
UKX
FTSE 100
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
ASX
CBA
Commonwealth Bank Of Aus...
ASX
FMG
Fortescue
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved